Supply-side and demand-side policies for biosimilars: an overview in 10 European member states-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Supply-side and demand-side policies for biosimilars: an overview in 10 European member states

Published:2017-01 Issue:1 Volume:5 Page:1307315
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Rémuzat Cécile¹,Kapuśniak Anna²,Caban Aleksandra²,Ionescu Dan³,Radière Guerric³,Mendoza Cyril³,Toumi Mondher⁴^ORCID

Affiliation:

1. Pricing and Market Access Department, Creativ-Ceutical, Paris, France

2. Pricing and Market Access Department, Creativ-Ceutical, Krakow, Poland

3. Global Pricing and Market Access Biopharmaceuticals Department, Sandoz International GmbH, Holzkirchen, Germany

4. Laboratoire de Santé Publique, Aix-Marseille Université, Université de la Méditerranée, Marseille, France

Funder

Sandoz International GmbH

Publisher

Informa UK Limited

Link

https://tandfonline.com/doi/pdf/10.1080/20016689.2017.1307315

Reference37 articles.

1. Pharmaceutical policies in European countries in response to the global financial crisis

2. The impact of pharmaceutical pricing and reimbursement policies on generics uptake: implementation of policy options on generics in 29 European countries─an overview

3. Key drivers for market penetration of biosimilars in Europe

4. What pricing and reimbursement policies to use for off-patent biologicals? – Results from the EBE 2014 biological medicines policy survey

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of biosimilar medicines in Spain: market dynamics, policies, evidence-based insights and avenues for a sustainable market;Expert Opinion on Biological Therapy;2024-06-06

2. Unveiling the Biosimilar Paradox of Oncologists’ Perceptions and Hesitations in South Korea: A Web-Based Survey Study;BioDrugs;2024-01-12

3. Clinical Benefit, Price, and Uptake for Cancer Biosimilars vs Reference Drugs in China;JAMA Network Open;2023-10-12

4. A Systematic Literature Review of Gaps and Challenges in Value Assessment of Biosimilars: An ISPOR Special Interest Group Report;Value in Health;2023-08

5. The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis;Health Research Policy and Systems;2023-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3